- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
ACAAI 2023 Annual Scientific Meeting Recap: Day 2
The second full day of the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting was filled with new data, important insights, and more.
ACAAI 2023
Poster Highlights the Importance of Education to Empower People of Color With Atopic Dermatitis
A successful educational program supported patients of color becoming their own health care advocates. Learn more about what might make a difference.
Practice Management Pearls From ACAAI: Tips for Going Green
Todd L. Sack, MD, shared tips for making greener decisions at your office, which will not only help the environment but may also help you save money and help you attract upcoming clinical stars and new patients.
ADORING 1 and 2 Results: Tapinarof Cream 1% Yields ‘Clinically Meaningful Pruritus Improvements’
Investigators report on the results of the identical studies, both of which indicated the treatment was effective and safe in children older than 2 and adults.
Tips for Difficult to Control Chronic Spontaneous Urticaria
Difficult to control chronic spontaneous urticaria can be frustrating for patients, but there are solutions and support available.
Are you attending the meeting? Share your insights and favorite moments by emailing DTEditor@mmhgroup.com.
